Clinical Trials Browser

Phase 1 × Advanced Cancer × 30 days × Clear all

NCT02797795 2026-05-13

A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers

Phase 1 Completed

Other solid neoplasm

Advanced Cancer